Abstract: O-Mannose glycans account up to 30 %o ftotal Oglycans in the brain. Previous synthesis and functional studies have only focused on the core M3 O-mannose glycans of adystroglycan, which are acausative factor for various muscular diseases.I nt his study,ahighly efficient chemoenzymatic strategy was developed that enabled the first collective synthesis of 63 core M1 and core M2 O-mannose glycans.T his chemoenzymatic strategy features the gram-scale chemical synthesis of five judiciously designed core structures,a nd the diversity-oriented modification of the core structures with three enzyme modules to provide58complex O-mannose glycans in alinear sequence that does not exceed four steps.The binding profiles of synthetic O-mannose glycans with apanel of lectins, antibodies,a nd brain proteins were also explored by using aprinted O-mannose glycan array.
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The protein a-dystroglycan (a-DG) is ah ighly glycosylated membrane-associated protein with more than half of the mass contributed by glycosylation. In addition to N-linked and conventional mucin-type O-GalNAc glycans,O -mannose glycans have been identified as the third most common glycosylation modification on a-DG.The O-mannose glycans on a-DG are known to play essential roles in muscle structure and functions.D efects in O-mannosylation lead to hypoglycosylation of a-DG,w hich is ac ausative factor for multiple forms of congenital muscular dystrophy (CMD). [1] TheOmannose glycans of a-DG have also been demonstrated to be involved in mesenchymal stem cell differentiation, lymphocytic choriomeningitis virus (LCMV) and Lassa fever virus (LFV) infection, and cancer metastasis. [2] TheO -mannose glycan structures of a-DG are highly heterogeneous,w ith various branching structures linked to three O-mannose cores (cores M1-3;Scheme 1a). [1] Core M3 can be further elaborated to ag lycosaminoglycan-like polysaccharide-containing structure (Scheme 1a). [1, 3] Thecore M3 structures have been exclusively identified on a-DG and have been confirmed as the only O-mannose core structures capable of directly binding to extracellular matrix (ECM) components. [1] Thec ore M1 and core M2 structures are far more abundant and diverse than the core M3 structures on a-DG,a nd these highly heterogeneous and complex structures have also been characterized in many other brain glycoproteins. [1, 4] However,t he biosynthetic pathway and the functional roles of the branching structures remain poorly understood. [1] Lewis x (Le x , V), sialyl Lewis x (sLe x , VI and VII) with one of the two sialic acid forms N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), and their substructures I-IV are the most common branching structures for core M1 and core M2 glycans (GlcNAc-A or GlcNAc-B;S cheme 1b). [1, 4] So far,o nly around 20 core M1 and core M2 structures have been well characterized. However,according to the known branching structures I-VII and their high abundance in brain glycoproteins,there are at least 56 putative non-sulfated core M1 and core M2 structures with appendant branching structures I-VII that potentially exist in various O-mannosylated proteins,i ncluding 7c ore M1 structures (Scheme 4b), 7s ymmetrical core M2 structures (Scheme 4d)a nd 42 asymmetrical core M2 structures (Scheme 5). To decipher the puzzling biosynthetic pathway and elucidate the functional roles of these highly heterogeneous O-mannose glycans in many brain glycoproteins,acollection of all putative core M1 and core M2 structures in sufficient amounts is highly desirable.U nfortunately,t he collective synthesis of these complex glycans,e specially the asymmetrical core M2 structures is very challenging.Previous chemical or chemoenzymatic syntheses have mainly focused on the simple core M1 glycans with branching structures I-III, [5] and the phosphorylated core M3 trisaccharide. [6] Except for as ymmetrical core M2 trisaccharide core structure, [7] no other core M2 symmetrical and asymmetrical structures have been synthesized. We describe herein the first collective synthesis of 63 putative nonsulfated core M1 and core M2 structures of O-mannose glycans.
Theoverall chemoenzymatic synthetic plan is depicted in Scheme 2. To overcome the limited availability of glycosyltransferases for the construction of core structures,f ive chemically synthesized core structures 1-5 were designed as the key intermediates for further enzymatic diversification. Thec ore structures 1 and 2 were designed for the enzymatic synthesis of linear core M1 and C6-branched core M1 isomers, respectively.T risaccharide 3 was designed to target the symmetrical core M2 structures and the asymmetrical tetrasaccharides 4 and 5 were designed for the selective enzymatic extension to generate all remaining 40 putative asymmetrical core M2 structures.
To acquire core structures 1-5 at gram scales for further enzymatic diversification, ac oncise chemical approach was designed using 2,6-diol 7,k nown monosaccharide imidate 14, [8] and disaccharide imidate 15 [9] as the key building blocks (Scheme 3). It was envisaged that 2,6-diol 7 could serve as the only acceptor required for the synthesis of core structures 2-5 through regio-and stereoselective glycosylation (Scheme 3). Regioselective glycosylation at the C6-OH or double glycosylation at the 2,6-diol of 7 with imidate 14 provided C6-branched disaccharide 10 (81 %) or C2,C6-branched trisaccharide 11 (85 %), respectively.T aking advantage of the difference in reactivity between the primary C6-OH and the secondary C2-OH of 7,aone-pot sequential glycosylation approach was applied for the synthesis of asymmetrical tetrasaccharide isomers 12 and 13 by simply changing the glycosylation sequence of donor 14 and 15.This operationally simple one-pot double glycosylation approach provided tetrasaccharides 12 (65 %f or two steps) and 13 (75 %f or two steps) in good yields.F or the synthesis of fully protected core M1 disaccharide 9,2 ,6-diol 7 was selectively protected with tert-butyldimethylsiyl (TBS) at the C6-OH. Theresulting mannoside 8 was glycosylated with imidate 14,y ielding the desired disaccharide 9 in 70 %y ield for two steps.N ext, Scheme 2. Synthetic plan. au nified three-step procedure was applied for the global deprotection of 9-13 to provide core structure 1-5.I nt his manner,t he gram-scale synthesis of all five designed core structures 1-5 was achieved, which makes it possible to explore the enzymatic diversification in the next stage.
Next, we turned our attention to enzymatic diversification of core structures 1-5 for the collective synthesis of core M1 and core M2 O-mannose glycans 16-71.P reviously,w e developed three enzyme modules to target three different glycosidic linkages presenting in branching structures II-VII (Scheme 1) for the synthesis of serine-appended core M1 Omannose glycans. [8] By taking advantage of the promiscuous substrate specificity of bacterial enzymes,weanticipated that these enzyme modules could also be applied for the synthesis of sterically hindered core M2 structures.A ss hown in Scheme 4a,e nzyme module 1i saone-pot three-enzyme system that was designed for b1-4-galactosylation to form the Galb1-4GlcNAc moiety. [10] Enzyme module 2isanother onepot three-enzyme system, which was designed for a2-3-sialylation to form both Neu5Aca2-3Gal and Neu5Gca2-3Gal units. [11] Enzyme module 3i saone-pot two-enzyme system that is applied for a1-3-fucosylation to form the Fuca1-3GlcNAc linkage. [12] Thes ynthesis of core M1 structures 16-21 was achieved through stepwise enzymatic extension of disaccharide 1 following the general procedures of three enzyme modules (see Scheme S1 and the Supporting Information). Accordingly, disaccharide 1 was firstly converted into LacNAc-terminated trisaccharide 16 (200 mg, 90 %) using enzyme module 1, then purified trisaccharide 16 was used as an acceptor by enzyme module 2f or the parallel synthesis of Neu5Aca2-3-linked sialoside 17 and Neu5Gca2-3-linked sialoside 18 by using ManNAc or ManNGc as the sialic acid precursor,r espectively.Isolated sialosides 17 (69 mg, 95 %), 18 (71 mg, 96 %), and trisaccharide 16 were elaborated in ap arallel fashion using enzyme module 3t oy ield Le x -containing structure 19 (45 mg, 89 %) and sLe x -containing core M1 structures 20 (31 mg, 80 %) and 21 (52 mg, 75 %). Thes ame stepwise assembly procedure was applied to the synthesis of C6-branched core M1 isomers 22-27 from disaccharide 2,a nd symmetrical core M2 O-mannose glycans 28-33 from trisaccharide 3.All these compounds were excellent substrates for the three enzyme modules,a ffording C6-branched core M1 isomers 22-27 (Scheme 4c)a nd symmetrical core M2 Omannose glycans 28-33 (Scheme 4d)i ng ood yields (see Schemes S2,S3, and the Supporting Information for details).
Thea symmetric core M2 glycans were divided into two subgroups in our synthetic plan according to the number of monosaccharide units on C2-and C6-branched structures.As shown in Scheme 5a,the first group with C2-branched "heavy chain" as the C2-branch has greater or equal number of sugar units to C6-branched structures.T he C2 "heavy chain"-branched core M2 asymmetric structures 34-55 can be derived from chemically prepared asymmetric tetrasaccharide 4 (Scheme 5a). In contrast, the C6 "heavy chain"-branched core M2 asymmetric structures 56-73 can be assembled from tetrasaccharide 5 (Scheme 5b). Theo verall synthetic Scheme for the assembly of C2 "heavy chain"-branched core M2 asymmetric structures 34-49 is depicted in Scheme 5a.S tarting from tetrasaccharide 4,s equential glycosylation using the three enzyme modules afforded 22 diverse complex core M2 asymmetric structures (34-55)i n 25-435 mg quantities.I ti sknown that LacNAc is ab etter acceptor than the sialyl LacNAc for Hpa1-3-FucT, [12e] therefore,f ucosylation of 44 or 45 with enzyme module 3a ffords both the mono-fucosylated 50 or 52 as the major products along with the double fucosylated 51 or 53 in one pot, respectively (Scheme 5a). Following as imilar enzymatic assembly strategy,t he C6 "heavy chain"-branched core M2 asymmetric structures 56-73 were also obtained in good yields (Scheme 5b,s ee Scheme S4 and the Supporting Information for details).
Despite the fact that O-mannose glycans account for up to one third of all O-linked glycans in the brain, and more than 50 O-mannosylated proteins have been identified, a-DG is the only O-mannosylated protein that has been intensively studied. [1] Most recently,the biosynthetic pathway of core M3 O-mannose glycans and their functional roles in various congenital muscular dystrophies have been well established. [1] In contrast to core M3 O-mannose glycans,which exclusively presented on a-DG,t he diverse and complex core M1 and core M2 O-mannose glycans have been identified on an umber of brain proteins.H owever,t he biosynthetic pathways of core M1 and core M2 O-mannose glycans have not been fully elucidated, and their biological functions or cognate receptors in the brain tissues are still unknown. The high prevalence of O-mannose glycans in the brain encour-aged us to screen their potential binding receptors with ap rinted microarray of our systematically synthesized core M1 and core M2 glycans.The binding affinities of plant lectins MAL-I, MAL-II, and SNAw ith O-mannose glycans were examined, and only MAL-I showed moderate binding with all the a2-3-sialic acid-capped LacNAc structures ( Figure S1 ). Ther ecombinant human Siglec-9 (hSiglec-9-Fc), chicken polyclonal anti-Neu5Gc antibody IgY (pChGc), human serum rich in anti-Neu5Gc antibody,and His-tagged typhoid toxin (PltB-His) were also screened on the array.The hSiglec-9-Fc exhibited moderate to strong binding to all sialylated Omannose glycans ( Figure S2 ). Both pChGc and anti-Neu5Gc-rich human serum showed strong binding for all the Neu5Gc-sialylated O-mannose glycans but not their Neu5Ac-counterparts ( Figure S2 ). Selective binding with PltB-His was observed for all the Neu5Ac-containing O-mannose glycans ( Figure S2 ). Theb inding profiles of three brain proteins, namely the recombinant human Fc-fusion CD33 (hSiglec-3), human L1 cell adhesion molecule (L1CAM/CD171), and human myelin-associated glycoprotein (MAG/Siglec-4a), were also screened with O-mannose glycan array,a nd only CD33 showed strong binding to all the sialylated O-mannose glycans ( Figure S3) .
In summary,a ne fficient chemoenzymatic approach has been developed for the diversity-oriented assembly of complex core M1 and core M2 O-mannose glycans.F ive core Scheme 5. a) Enzymatic modular assemblyo fC 2" heavychain"-branchedasymmetrical core M2 glycans 34-55 fromtetrasaccharide 4 (50 and 51 were derivedf rom 44 in one pot, 52 and 53 were derived from 45 in onep ot). b) Enzymatic modular assemblyofC6" heavychain"-branched asymmetrical core M2 glycans 56-73 from tetrasaccharide 5 (68 and 69 were derivedf rom 66 in onep ot, 70 and 71 were derivedfrom 67 in onep ot).
structures (1-5)d esigned to target different O-mannose glycan subgroups were obtained on ag ram scale through concise chemical synthesis.T he enzymatic diversification of core structures 1-5 with three enzyme modules through diversity-oriented parallel enzymatic glycosylation provided 58 core M1 and core M2 structures in al inear sequence that does not exceeded four steps.The 63 diverse chemoenzymatically synthesized O-mannose glycans,5 5o fw hich were synthesized for the first time,c onstitute the most comprehensive O-mannose glycan library to date.T hese systematically synthesized O-mannose glycans enabled exploration of their binding profiles with different lectins,a ntibodies,a nd brain proteins by using aprinted O-mannose glycan array.A cross-comparison of O-mannose glycans with other conventional O-GalNAc glycans and N-glycans,a sw ell as further functional studies of O-mannose glycans on brain proteins, are currently under investigation.
